Makassar, Indonesia 04/06/2026/BioVax TB/ – Reliable molecular research depends not only on advanced analytical instruments but also on the careful preparation of laboratory materials that ensure every experiment produces trustworthy results. One of these essential materials is agarose gel, which serves as the separation matrix during DNA electrophoresis. Recognizing its importance, the activity entitled “Preparation...
Makassar, Indonesia 22/06/2026/BioVax TB/ – On 22 October 2025, a laboratory activity entitled “PCR Gen rv3875–rv2873 and rv3874–rv2389c” was successfully conducted at the Laboratory of the Hasanuddin University Medical Research Center (HUMRC), Faculty of Medicine, Hasanuddin University (Lab HUMRC FK UNHAS). This activity focused on the polymerase chain reaction (PCR) amplification of the rv3875–rv2873 and...
Makassar, Indonesia 04/06/2026/BioVax TB/ – As part of ongoing efforts to strengthen international scientific collaboration and accelerate innovation in infectious disease research, Prof. Dr. Nasrum Massi, Ph.D., Sp.MK(K) participated in an academic visit and scientific forum held at the University of Leicester, United Kingdom, on 28–29 April 2025. The activity brought together multidisciplinary researchers from the United...
Makassar, Indonesia 24/04/2025/BioVax TB/Scientific collaboration plays a vital role in addressing complex global health challenges and accelerating the development of innovative solutions that benefit society. In line with this commitment, a large-scale scientific gathering was successfully conducted on April 24, 2025, at The Westin Hotel Jakarta, bringing together experts, researchers, academics, healthcare professionals, and representatives...
The BioVax team recently announced a breakthrough in tuberculosis vaccine development. Early trials show promising results, paving the way for advanced studies in combating TB...
Representatives from BioVax shared their latest findings at the annual Global Tuberculosis Summit, fostering collaborations with international researchers...